Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T70381 |
GSK2793660 free base
|
||
GSK-2793660 is a cathepsin C inhibitor that may be useful in the treatment of cystic fibrosis, noncystic fibrosis bronchiectasis, ANCA-associated vasculitis and bronchiectasis. | |||
T70380 |
ZBH-1205
|
||
ZBH-1205 is a novel camptothecin derivative, revealing potent antitumor activities mainly through cell apoptosis pathway, being more effective than cpt-11 and sn38 at inhibiting topoismerase-1 |